Open original FDA record ↗Recall record
- FDA identifier
- Z-2063-2016
- Company in FDA record
- Medtest Holdings, Inc.
- FDA record creation date
- Jun 28, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Deterioration in performance of the Liquid Stable (LS) 2-Part HOMOCYSTEINE REAGENT resulting in under recovery. The manufacturer has indicated that the HOMOCYSTEINE REAGENT lot listed above shows deterioration in assay performance manifesting itself by under recovery of Homocysteine in Controls and Patient Samples. The cause of this deterioration has been attributed to a loss of reductant activity in Reagent 1. Testing performed indicated that the affected lot is at the limit of acceptable clinical performance. This observation was consistent across the reportable range of the assay. For this reason, do not continue to use affected reagent lot. Test data generated to date will be acceptable where validity control specifiCations have been met.
Source facts
- Action
- On 4/3/2015, Urgent Field Safety Notice notifications were sent to the affected customers via email with instructions for identifying and destroying the affected product. The recall notification included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification.
- Initiated
- 2015-04-03
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2016-07-05
- Distribution
- MI, MN, NJ, IL, NY. US Only.
- Recall number
- Z-2063-2016
- Recall status
- Terminated
- CDRH record ID
- 146910
- FDA record created
- 2016-06-28
- Recall event number
- 74234